Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Agios Pharmaceuticals Company Profile (NASDAQ:AGIO)

Consensus Ratings for Agios Pharmaceuticals (NASDAQ:AGIO) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $52.96 (38.39% upside)

Analysts' Ratings History for Agios Pharmaceuticals (NASDAQ:AGIO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/1/2014Citigroup Inc.Initiated CoverageBuy$58.00ViewTweet This Rating  Share This Rating on StockTwits
6/16/2014JPMorgan Chase & Co.Reiterated RatingOverweight$55.00 -> $60.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014ZacksUpgradeUnderperform -> Neutral$44.80ViewTweet This Rating  Share This Rating on StockTwits
4/7/2014Leerink SwannBoost Price Target$51.00 -> $65.00ViewTweet This Rating  Share This Rating on StockTwits
4/7/2014JPMorgan Chase & Co.UpgradeNeutral -> Overweight$40.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
3/28/2014JPMorgan Chase & Co.Boost Price Target$35.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014ZacksDowngradeNeutral -> Underperform$40.90ViewTweet This Rating  Share This Rating on StockTwits
3/7/2014Leerink SwannBoost Price Target$38.00 -> $51.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/19/2013JPMorgan Chase & Co.Initiated CoverageNeutral$35.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013Goldman SachsInitiated CoverageBuy$37.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2012 forward)